ADVM icon

Adverum Biotechnologies
ADVM

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$4.5
8% upside
High target

2 analyst ratings

positive
2  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Matthew Caufield
67% 1-yr ADVM win rate
17 Nov ‘25 16 days ago
RBC Capital
RBC Capital
Lisa Walter
28 Oct ‘25 1 month ago